Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ENVB

Enveric Biosciences Inc

May 08 • 04:00PM ET

2.85

-0.32 -10.09 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: DRUG GHRS CMPS ATAI BIVI

| Held by: PSIL

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-40.85	Insider Own	14.34%	Shs Outstand	1.99M	Perf Week	-28.57%
Market Cap	5.66M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	1.70M	Perf Month	39.71%
Enterprise Value	0.98M	PEG	-	EPS next Q	-	Inst Own	15.97%	Short Float	3.71%	Perf Quarter	20.25%
Income	-12.13M	P/S	-	EPS this Y	-	Inst Trans	7.34%	Short Ratio	0.02	Perf Half Y	-60.64%
Sales	0.00M	P/B	0.72	EPS next Y	-	ROA	-214.51%	Short Interest	0.06M	Perf YTD	-21.49%
Book/sh	3.94	P/C	1.21	EPS next 5Y	-	ROE	-304.04%	52W High	17.84 -84.03%	Perf Year	-81.30%
Cash/sh	2.36	P/FCF	-	EPS past 3/5Y	75.07% 67.96%	ROIC	-209.98%	52W Low	1.71 66.67%	Perf 3Y	-99.23%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	14.15% 23.65%	Perf 5Y	-99.99%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	84.04%	Oper. Margin	-	ATR (14)	0.78	Perf 10Y	-100.00%
Dividend Ex-Date	-	Quick Ratio	5.33	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	44.89	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	5.33	EPS Q/Q	93.42%	SMA20	-17.88%	Beta	1.23	Target Price	1800.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	10.17%	Rel Volume	0.07	Prev Close	3.17
Employees	6	LT Debt/Eq	0.00	Earnings	Mar 27 BMO	SMA200	-54.57%	Avg Volume	4.13M	Price	2.85
IPO	Aug 22, 1995	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	283,009	Change	-10.09%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)